INS and metabolic syndrome: Majority of the 302 patients had type 2 diabetes, were non-smoker, centrally obese, non-insulin user and complicated with dyslipidemia, stage 2 CKD, and microalbuminuria (3.0 ± 1.1 mg/mmol) (Table 2).